As outlined in Table 1, it is evident that the PD-L1-positive group exhibited a higher incidence of patients with high-grade endometrial cancer compared to the PD-L1-negative group (37% vs. 19.1%, p = 0.004). The gene discussed is CD274; the disease is endometrial cancer.